Atlas Trials

NSE/Alb as a Prognostic Biomarker for Lung Cancer

Clinical trial NCT03724604 · UNKNOWN

Trial details

NCT number
NCT03724604
Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Status
UNKNOWN
Study type
OBSERVATIONAL
Carcinoma, Non-Small-Cell Lung
Start date
2017-01-01
Primary completion
2019-06-30
Enrollment
202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.